Evidence map›Paper›PMID 42866132›Full record

ArticleJournal of thoracic disease2026

Skeletal muscle depletion during neoadjuvant chemoimmunotherapy predicts postoperative complications in non-small cell lung cancer: a retrospective cohort study.

Wei Feng, Xin Wang, Heng Du, Guowei Che

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei FengDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xin WangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Heng DuDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Guowei CheDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: For patients with resectable locally advanced non-small cell lung cancer (NSCLC), surgical resection preceded by neoadjuvant chemoimmunotherapy (nICT) has become the standard treatment strategy. However, the triple physiological burden imposed by chemotherapy, immunotherapy, and ongoing tumor metabolism may compromise functional reserve and increase surgical risk. Identifying patients at high risk for postoperative complications remains a critical challenge in perioperative management. This study aimed to characterize dynamic changes in skeletal muscle and adipose tissue during nICT, to identify independent predictors of postoperative complications, and to evaluate the incremental predictive value of dynamic body composition metrics over established clinical variables. Methods: This retrospective study included 160 patients with resectable NSCLC who underwent surgical resection following nICT between June 2024 and December 2025. Skeletal muscle index (SMI), skeletal muscle density (SMD), visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) were quantified at the L3 vertebral level on computed tomography (CT) images obtained before and after treatment. Dynamic changes (Δ) were calculated as the difference between pre-treatment and post-treatment values. The primary outcome was postoperative complications of Clavien-Dindo (CD) grade ≥II. Three predictive models were constructed and compared using area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: Following nICT, skeletal muscle metrics decreased significantly (median ΔSMI, -0.54 cm Conclusions: Dynamic loss of skeletal muscle during nICT, as assessed on routine CT images, was independently associated with postoperative complications in patients with resectable NSCLC. Compared with baseline body-composition parameters and conventional clinical indices, longitudinal change in SMI (ΔSMI) provided better discrimination of perioperative risk. Because ΔSMI can be derived from CT scans already obtained for treatment-response assessment, it may serve as a practical, low-burden imaging biomarker to support preoperative risk stratification and identify patients who may benefit from targeted prehabilitation.

Indexed as

body compositionneoadjuvant chemoimmunotherapy (nICT)non-small cell lung cancer (NSCLC)postoperative complicationsSkeletal muscle index (SMI)

Identifiers

PMID42866132
PMCPMC13655816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.